Evidence map›Paper›PMID 36190401›Full record

ArticleMicrobiology spectrum2022

Iron-Modified Blood Culture Media Allow for the Rapid Diagnosis and Isolation of the Slow-Growing Pathogen Francisella tularensis.

Efi Makdasi, Yafit Atiya-Nasagi, David Gur, Itai Glinert, Shlomo Shmaya, Elad Milrot, Theodor Chitlaru, Emanuelle Mamroud, Orly Laskar, Ofir Schuster

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Efi MakdasiIsrael Institute for Biological Researchgrid.419290.7, Ness-Ziona, Israel.ORCID 0000-0001-5168-6872
Yafit Atiya-NasagiIsrael Institute for Biological Researchgrid.419290.7, Ness-Ziona, Israel.
David GurIsrael Institute for Biological Researchgrid.419290.7, Ness-Ziona, Israel.
Itai GlinertIsrael Institute for Biological Researchgrid.419290.7, Ness-Ziona, Israel.
Shlomo ShmayaIsrael Institute for Biological Researchgrid.419290.7, Ness-Ziona, Israel.
Elad MilrotIsrael Institute for Biological Researchgrid.419290.7, Ness-Ziona, Israel.
Theodor ChitlaruIsrael Institute for Biological Researchgrid.419290.7, Ness-Ziona, Israel.ORCID 0000-0002-6351-0820
Emanuelle MamroudIsrael Institute for Biological Researchgrid.419290.7, Ness-Ziona, Israel.ORCID 0000-0001-5685-293X
Orly Laskar *Israel Institute for Biological Researchgrid.419290.7, Ness-Ziona, Israel.
Ofir Schuster *Israel Institute for Biological Researchgrid.419290.7, Ness-Ziona, Israel.ORCID 0000-0001-6379-9292
Israel Institute for Biological Research · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The life-threatening disease tularemia is caused by Francisella tularensis, an intracellular Gram-negative bacterial pathogen. Due to the high mortality rates of the disease, as well as the low respiratory infectious dose, F. tularensis is categorized as a Tier 1 bioterror agent. The identification and isolation from clinical blood cultures of F. tularensis are complicated by its slow growth. Iron was shown to be one of the limiting nutrients required for F. tularensis metabolism and growth. Bacterial growth was shown to be restricted or enhanced in the absence or addition of iron. In this study, we tested the beneficial effect of enhanced iron concentrations on expediting F. tularensis blood culture diagnostics. Accordingly, bacterial growth rates in blood cultures with or without Fe

Indexed as

Francisella tularensisTularemiaAnti-Bacterial AgentsBlood CultureHumansIronAnti-Bacterial AgentsIronBactec vialsbacterial diagnosticsbacterial growthblood cultureFrancisella tularensisirontularemia

Identifiers

PMID36190401
PMCPMC9603284
OpenAlexW4300689363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.